MKI67 and glioblastoma: With Ki67 antibody labeling cells in the active cell cycle and BrdU labeling cells in the S-phase, we demonstrated that circXPO1 knockdown arrested GBM cell cycle progression in the S-phase from ~30% to ~20% (Figure 2E).